The effect of sodium pyruvate on the elimination of sulfadiazine in slow acetylation rabbits

Kuang Yang Hsu, Yih Ho, Hsing Hwei Chang

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to investigate the mechanism by which pyruvic acid (PA) affects the pharmacokinetics of sulfadiazine (SDZ) and its metabolite, acetylsulfadiazine (AcSDZ) in slow acetylation rabbits. After IV bolus administration of equal molar doses of SDZ (20 mg/kg) and AcSDZ to rabbits during infusion of 0.9% NaCl or PA, the plasma concentrations of both SDZ and AcSDZ were quantitated by an HPLC method. The results showed that the elimination of SDZ in slow acetylation rabbits was significantly increased (p <0.05) when the plasma PA concentration was maintained at ≃ 100 μg/mL. In addition, the area under the plasma concentration-time curve (AUC) of AcSDZ formed from SDZ was significantly decreased (p <0.005). The formation fraction (F) of AcSDZ formed from SDZ was also significantly decreased from 0.28 ± 0.08 to 0.13 ± 0.04 (p <0.005). However, the pharmacokinetics of AcSDZ after IV bolus administration were not changed during PA infusion. The renal excretion of SDZ was significantly increased (p <0.005) in PA infused rabbits, indicating that the change in SDZ elimination in slow acetylation rabbits during PA infusion was primarily due to increased renal excretion.

Original languageEnglish
Pages (from-to)375-386
Number of pages12
JournalChinese Pharmaceutical Journal
Volume48
Issue number5
Publication statusPublished - Oct 1996

Fingerprint

Sulfadiazine
Acetylation
Pyruvic Acid
Sodium
Rabbits
Acids
Pharmacokinetics
Plasmas
Metabolites
Area Under Curve
High Pressure Liquid Chromatography

Keywords

  • acetylsulfadiazine
  • elimination
  • pyruvic acid
  • sulfadiazine

ASJC Scopus subject areas

  • Bioengineering
  • Pharmaceutical Science

Cite this

The effect of sodium pyruvate on the elimination of sulfadiazine in slow acetylation rabbits. / Hsu, Kuang Yang; Ho, Yih; Chang, Hsing Hwei.

In: Chinese Pharmaceutical Journal, Vol. 48, No. 5, 10.1996, p. 375-386.

Research output: Contribution to journalArticle

@article{f1c72ca5217547de8bb6391d7117a985,
title = "The effect of sodium pyruvate on the elimination of sulfadiazine in slow acetylation rabbits",
abstract = "The purpose of this study was to investigate the mechanism by which pyruvic acid (PA) affects the pharmacokinetics of sulfadiazine (SDZ) and its metabolite, acetylsulfadiazine (AcSDZ) in slow acetylation rabbits. After IV bolus administration of equal molar doses of SDZ (20 mg/kg) and AcSDZ to rabbits during infusion of 0.9{\%} NaCl or PA, the plasma concentrations of both SDZ and AcSDZ were quantitated by an HPLC method. The results showed that the elimination of SDZ in slow acetylation rabbits was significantly increased (p <0.05) when the plasma PA concentration was maintained at ≃ 100 μg/mL. In addition, the area under the plasma concentration-time curve (AUC) of AcSDZ formed from SDZ was significantly decreased (p <0.005). The formation fraction (F) of AcSDZ formed from SDZ was also significantly decreased from 0.28 ± 0.08 to 0.13 ± 0.04 (p <0.005). However, the pharmacokinetics of AcSDZ after IV bolus administration were not changed during PA infusion. The renal excretion of SDZ was significantly increased (p <0.005) in PA infused rabbits, indicating that the change in SDZ elimination in slow acetylation rabbits during PA infusion was primarily due to increased renal excretion.",
keywords = "acetylsulfadiazine, elimination, pyruvic acid, sulfadiazine",
author = "Hsu, {Kuang Yang} and Yih Ho and Chang, {Hsing Hwei}",
year = "1996",
month = "10",
language = "English",
volume = "48",
pages = "375--386",
journal = "Taiwan Pharmaceutical Journal",
issn = "1016-1015",
publisher = "臺灣藥學會",
number = "5",

}

TY - JOUR

T1 - The effect of sodium pyruvate on the elimination of sulfadiazine in slow acetylation rabbits

AU - Hsu, Kuang Yang

AU - Ho, Yih

AU - Chang, Hsing Hwei

PY - 1996/10

Y1 - 1996/10

N2 - The purpose of this study was to investigate the mechanism by which pyruvic acid (PA) affects the pharmacokinetics of sulfadiazine (SDZ) and its metabolite, acetylsulfadiazine (AcSDZ) in slow acetylation rabbits. After IV bolus administration of equal molar doses of SDZ (20 mg/kg) and AcSDZ to rabbits during infusion of 0.9% NaCl or PA, the plasma concentrations of both SDZ and AcSDZ were quantitated by an HPLC method. The results showed that the elimination of SDZ in slow acetylation rabbits was significantly increased (p <0.05) when the plasma PA concentration was maintained at ≃ 100 μg/mL. In addition, the area under the plasma concentration-time curve (AUC) of AcSDZ formed from SDZ was significantly decreased (p <0.005). The formation fraction (F) of AcSDZ formed from SDZ was also significantly decreased from 0.28 ± 0.08 to 0.13 ± 0.04 (p <0.005). However, the pharmacokinetics of AcSDZ after IV bolus administration were not changed during PA infusion. The renal excretion of SDZ was significantly increased (p <0.005) in PA infused rabbits, indicating that the change in SDZ elimination in slow acetylation rabbits during PA infusion was primarily due to increased renal excretion.

AB - The purpose of this study was to investigate the mechanism by which pyruvic acid (PA) affects the pharmacokinetics of sulfadiazine (SDZ) and its metabolite, acetylsulfadiazine (AcSDZ) in slow acetylation rabbits. After IV bolus administration of equal molar doses of SDZ (20 mg/kg) and AcSDZ to rabbits during infusion of 0.9% NaCl or PA, the plasma concentrations of both SDZ and AcSDZ were quantitated by an HPLC method. The results showed that the elimination of SDZ in slow acetylation rabbits was significantly increased (p <0.05) when the plasma PA concentration was maintained at ≃ 100 μg/mL. In addition, the area under the plasma concentration-time curve (AUC) of AcSDZ formed from SDZ was significantly decreased (p <0.005). The formation fraction (F) of AcSDZ formed from SDZ was also significantly decreased from 0.28 ± 0.08 to 0.13 ± 0.04 (p <0.005). However, the pharmacokinetics of AcSDZ after IV bolus administration were not changed during PA infusion. The renal excretion of SDZ was significantly increased (p <0.005) in PA infused rabbits, indicating that the change in SDZ elimination in slow acetylation rabbits during PA infusion was primarily due to increased renal excretion.

KW - acetylsulfadiazine

KW - elimination

KW - pyruvic acid

KW - sulfadiazine

UR - http://www.scopus.com/inward/record.url?scp=12644270190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644270190&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:12644270190

VL - 48

SP - 375

EP - 386

JO - Taiwan Pharmaceutical Journal

JF - Taiwan Pharmaceutical Journal

SN - 1016-1015

IS - 5

ER -